文献速递外周动脉疾病

慢性肢体威胁性缺血腘动脉及膝下动脉腔内干预前瞻性注册研究的短期结局

Short Term Outcomes of a Prospective Registry of Popliteal and Infrapopliteal Endovascular Interventions for Chronic Limb Threatening Ischaemia.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-09-26

该研究分析荷兰THRILLER注册研究中首批1000例慢性肢体威胁性缺血(CLTI)患者的腘动脉或膝下动脉腔内血运重建数据,覆盖840例患者(947条肢体)。结果显示WIfI分期1-4期3个月保肢率分别为100.0%、96.9%、94.9%、86.1%,无截肢生存率分别为96.9%、93.2%、86.6%、76.4%,WIfI分类可独立预测保肢与无截肢生存。

要点

  • WIfI分期1-4期3个月保肢率分别为100.0%、96.9%、94.9%、86.1%(p < .001)。
  • WIfI分期1-4期3个月无截肢生存率分别为96.9%、93.2%、86.6%、76.4%(p < .001)。
  • 6-8周随访时腘动脉病变一期通畅率为86.4%,胫动脉病变为74.3%。

核心结论

  • THRILLER注册研究提供了CLTI腔内干预结局的大样本前瞻性数据库。
  • 腘动脉及膝下动脉腔内血运重建治疗CLTI是安全的,初始技术成功的干预3个月保肢率与生存率较高。
  • WIfI分类可独立可靠预测3个月保肢率和无截肢生存率。

研究设计与样本

  • 本研究为荷兰慢性下肢威胁性缺血注册研究(THRILLER)首批1000例干预的分析。
  • 纳入荷兰七家医院因CLTI接受腘动脉或膝下动脉腔内血运重建的所有患者。
  • 共840例患者(947条肢体),2021年2月至2023年7月间完成1000例腔内手术,治疗486处腘动脉病变和1209处胫动脉病变。
  • 主要结局为3个月保肢率和无截肢生存率(AFS),采用Kaplan-Meier法估计;次要结局为手术并发症和一期通畅率。

主要发现

  • WIfI分期1、2、3、4期肢体分别占16.8%、17.2%、25.4%、40.6%。
  • 因动脉穿孔、急性血栓形成和远端栓塞导致技术成功受限的比例分别为8.7%、1.0%和2.3%。
  • WIfI分期1-4期3个月保肢率分别为100.0%、96.9%、94.9%、86.1%(p < .001)。
  • WIfI分期1-4期3个月无截肢生存率分别为96.9%、93.2%、86.6%、76.4%(p < .001)。
  • 6-8周随访时一期通畅率腘动脉病变为86.4%,胫动脉病变为74.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The prevalence of chronic limb threatening ischaemia (CLTI) is increasing worldwide, resulting in the need for more patients to undergo revascularisation, especially for below the knee pathology. Nevertheless, prospective data on below the knee endovascular interventions are lacking. The aim of the study was to provide large scale, real world data on procedural and short term outcomes of popliteal and infrapopliteal endovascular interventions in patients with CLTI. METHODS: This study is an analysis of the first 1 000 interventions of the Dutch Chronic Lower Limb Threatening Ischaemia Registry (THRILLER). It includes all patients with CLTI undergoing popliteal or infrapopliteal endovascular revascularisation in seven hospitals in the Netherlands. The primary outcomes were limb salvage and amputation free survival (AFS) at three months estimated by the Kaplan-Meier method. Secondary outcomes were procedural complications and primary patency. RESULTS: Between February 2021 and July 2023, 1 000 endovascular procedures were performed in 840 patients (947 limbs), treating 486 popliteal and 1 209 tibial lesions. Wound, Ischaemia, and foot Infection (WIfI) stages 1 - 4 were present in 16.8%, 17.2%, 25.4%, and 40.6% of the limbs, respectively. Technical success was hampered by arterial perforation, acute thrombosis, and distal embolisation in 8.7%, 1.0%, and 2.3% of the interventions, respectively. Limb salvage was 100.0%, 96.9%, 94.9%, and 86.1% (p < .001), whereas AFS was 96.9%, 93.2%, 86.6%, and 76.4% for WIfI stages 1 - 4 at three months (p < .001), respectively. Primary patency at the 6 - 8 week visit was 86.4% for popliteal and 74.3% for tibial lesions, respectively. CONCLUSION: THRILLER presents a large prospective database on outcomes of endovascular CLTI interventions. Popliteal and infrapopliteal endovascular revascularisation for CLTI is safe. Interventions with initial technical success have high rates of limb salvage and survival at three months. The WIfI classification provides a reliable instrument to predict limb salvage and AFS independently at three months.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nugteren MJ, Hazenberg CEVB, Bakker OJ, et al. Short Term Outcomes of a Prospective Registry of Popliteal and Infrapopliteal Endovascular Interventions for Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2024. PMID: 39341420. doi:10.1016/j.ejvs.2024.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。